Clinical trials
Prostatic Hyperplasia trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 3 |
| Recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 5 |
| Pierre Fabre Medicament | 3 |
| Fundacio Puigvert | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Bioaraba Health Research Institute | 1 |
| Boston Scientific Corporation | 1 |
| Complexo Hospitalario Universitario de A Coruña | 1 |
| Fundacion Miguel Servet | 1 |
| Germans Trias i Pujol Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 28 |
| Lower Urinary Tract Symptoms | 9 |
| Prostatic Neoplasms | 2 |
| Urinary Bladder, Overactive | 2 |
| Urinary Retention | 2 |
| Inflammation | 1 |
| Metabolic Syndrome | 1 |
| Urinary Bladder Neoplasms | 1 |
Trials
Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.